This sizable study offers valuable information about newly discovered significantly mutated genes, elucidates tumor heterogeneity with respect to patient and tumor characteristics, and reinforces prior research findings regarding the association between somatic mutations in BRAF and DS-survival while providing additional insights into this association with respect to patient sex and tumor site. The gene discussed is BRAF; the disease is neoplasm.